Swati Mudshingkar, Gita Nataraj, Sujata Baveja, Farah Jijina, Preeti Mehta
Indian J Hematol Blood Transfus. 2010 Jun;26(2):49-55. doi: 10.1007/s12288-010-0029-z. Epub 2010 Sep 30.
Bacterial and fungal infections are a major cause of morbidity and mortality among neutropenic patients. The choice of empiric antimicrobial regimen is based on susceptibility pattern of locally prevalent pathogens. From 64 febrile neutropenic patients with clinical sepsis, blood and other appropriate clinical specimens were processed to determine bacterial and fungal spectrum and their antimicrobial susceptibility pattern. Risk factors for developing sepsis were determined by case-control study. 68 organisms were recovered. Fifteen (22.05%) were Gram-positive cocci with predominance of methicillin Sensitive S. aureus (10.29%), 47 (69.11%) were Gram-negative rods with predominance of Klebsiella pneumoniae (30.88%) and four were Non albicans Candida. 81% and 60% of Klebsiella and E. coli were ESBL producers. All species of Candida were sensitive to amphoterecin B and voriconazole. Duration and extent of neutropenia, chemotherapy, immunosuppressive therapy, altered mucosal barriers and presence of central venous lines were statistically significant risk factors for developing sepsis. Gram-negative bacteria were the predominant isolates. The choice of therapy in neutropenic patients should be formulated based on local spectrum of microbes and local and regional resistance patterns.
细菌和真菌感染是中性粒细胞减少患者发病和死亡的主要原因。经验性抗菌方案的选择基于当地流行病原体的药敏模式。对64例伴有临床脓毒症的发热性中性粒细胞减少患者,对血液及其他合适的临床标本进行处理,以确定细菌和真菌谱及其抗菌药敏模式。通过病例对照研究确定发生脓毒症的危险因素。共分离出68株微生物。15株(22.05%)为革兰氏阳性球菌,以甲氧西林敏感金黄色葡萄球菌为主(10.29%),47株(69.11%)为革兰氏阴性杆菌,以肺炎克雷伯菌为主(30.88%),4株为非白念珠菌。81%的克雷伯菌和60%的大肠杆菌产超广谱β-内酰胺酶(ESBL)。所有念珠菌属对两性霉素B和伏立康唑敏感。中性粒细胞减少的持续时间和程度、化疗、免疫抑制治疗、黏膜屏障改变及中心静脉置管的存在是发生脓毒症的统计学显著危险因素。革兰氏阴性菌是主要分离菌。中性粒细胞减少患者的治疗选择应根据当地微生物谱及当地和区域耐药模式来制定。